Susanna Naggie MD MHS
Associate Professor, Medicine, Duke University School of Medicine; Director, Infectious Disease Research, Duke Clinical Research Institute; Staff Physician, Durham VA Medical Center
Join to view full profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-684-8111
Dr. Naggie is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Infectious Disease, 2007 - 2009- Duke University HospitalResidency, Internal Medicine, 2002 - 2005
Johns Hopkins University School of MedicineClass of 2002
Certifications & Licensure
NC State Medical License 2002 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection Start of enrollment: 2014 May 30
- Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection Start of enrollment: 2019 Nov 20
Publications & Presentations
PubMed
- Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial.Carolyn T Bramante, Thomas G Stewart, David R Boulware, Matthew W McCarthy, Yue Gao
Clinical Infectious Diseases. 2026-06-04 - Non-Hispanic Black Persons With HIV Have a Lower Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Clinically Significant Fibrosis Compared to Non-H...Tinsay A Woreta, Samer Gawrieh, Laura A Wilson, Yuchen Xin, Eduardo Vilar-Gomez
Open Forum Infectious Diseases. 2026-05-01 - 23 citationsAASLD ISDA Practice Guideline on treatment of chronic hepatitis B.Marc G Ghany, Calvin Q Pan, Anna S Lok, Jordan J Feld, Joseph K Lim
Hepatology. 2026-04-01
Press Mentions
What Ivermectin Can (And Can’t) DoMarch 31st, 2025- Asthma Drug Did Not Reduce Symptom Duration in Mild to Moderate COVIDOctober 22nd, 2024
- Time to Sustained Recovery Among Outpatients with COVID-19 Receiving Montelukast vs PlaceboOctober 18th, 2024
Grant Support
- CTSA UM1 at Duke UniversityDUKE UNIVERSITY2025–2032
- Combating Related Epidemics in HCV through Simplified Testing and Treatment (CREST)DUKE UNIVERSITY2025–2030
- Combating Related Epidemics in HCV through Simplified Testing and Treatment (CREST)DUKE UNIVERSITY2025–2030
- Center for AIDS ResearchDUKE UNIVERSITY2005–2030
- Early Phase Clinical Trial Units (EPCTU)DUKE UNIVERSITY2022–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
